Company intelligence / Profile preview
Nanogen Pharmaceutical Biotechnology JSC
Thu Duc City, Ho Chi Minh City, Vietnamnanogenpharma.com ↗
- Ownership
- Private
- Employees
- ~76
- Development stage
- Other
01
Overview
Nanogen has successfully commercialized biosimilar biological drugs such as PEGNANO for hepatitis treatment since around 2010. It has expanded into oncology treatments with products like FACEPTOR and MIRACEL targeting multiple cancers. The company developed Vietnam’s first COVID19 vaccine candidate NANO COVAX which reached Phase III clinical trials. Their manufacturing facilities meet WHO-GMP and TGA-GMP standards supporting both domestic supply and exports to over fifteen countries worldwide.
They continue R&D on monoclonal antibodies for cancer immunotherapy alongside their existing portfolio of biopharmaceutical APIs and finished injectable products.
- Therapeutic areas
- OncologyInfectious DiseasesHematology
- Modalities
- Biosimilars (biological drugs similar to approved biologics)Recombinant DNA/protein therapeuticsTherapeutic injections including monoclonal antibodies and vaccinesActive pharmaceutical ingredients (APIs) production
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Beyond the preview
Go deeper on Nanogen Pharmaceutical Biotechnology JSC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nanogen Pharmaceutical Biotechnology JSC.